Security key
88032L605
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX)
CUSIP: 88032L605
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 1,228,920
- Total 13F value
- $4,253,022
- Share change
- +1,210,091
- SEC-reported price per share
- $3.46
- Number of holders
- 19
- Value change
- +$4,189,827
- Number of buys
- 15
- Number of sells
- 4
- Shares outstanding
- 26,414,314
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q3 2024
Institutions
19
Top holders
10
TENX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
TENAX THERAPEUTICS, INC. SEC filings
TENAX THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88032L605
Recent filing periods:
Ownership snapshot
Top reported holders of TENX - TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vestal Point Capital, LP
Disclosed value leader
Vestal Point Capital, LP
Comparable rows
11/14
Latest evidence
30 Sep 2024
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
3 rows are not safely comparable across share classes.
13D/G row: Vestal Point Capital, LP
Showing 1-6 of 14 holder rows.
Quick read
Vestal Point Capital, LP leads the comparable SEC ownership view at 9.9%.
11 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Vestal Point Capital, LP
9.9%
GEODE CAPITAL MANAGEMENT, LLC
0.04%
Qube Research & Technologies Ltd
0.02%
UBS Group AG
0.01%
Tower Research Capital LLC (TRC)
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vestal Point Capital, LP |
13D/G
|
9.9%
|
$18,525,720
2,470,096 shares
|
$0 | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.04%
|
$33,564
11,041 shares
|
— | 30 Jun 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
0.02%
|
$13,397
4,407 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
0.01%
|
$4,519
1,499 shares
|
— | 30 Jun 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$2,897
961 shares
|
— | 30 Jun 2024 |
| CIBC Private Wealth Group LLC |
13F
Company
|
0%
|
$1,087
343 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
1,228,920
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
10
Q3 2024 holders
19
Holder diff
9
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend